top of page
Latest News
Search
A New Single-Tablet Option for HIV's "Forgotten Population" Could Change Lives. Will Policy Let It?
New Phase 3 data show a single-tablet regimen of bictegravir/lenacapavir could finally bring one-pill simplicity to long-term HIV survivors locked into complex regimens by decades of drug resistance. The science is closing the treatment gap. Will our policy systems do the same?
Travis Roppolo
Mar 309 min read
HRSA's 340B Pilot Tests What Already Works While Ignoring What Doesn't
HRSA's 340B pilot program replicates existing successful models rather than addressing structural program exploitation.
Travis Roppolo
Aug 10, 20255 min read
We Need Your Support Today!
bottom of page